Suppliers

Catalent Pharma Solutions

Catalent

Catalent is your strategic partner for biologic drug development success. We create smart, tailored solutions with our novel SMARTag™ ADC Technology, our market leading GPEx®​ cell line expression system , expanded biomanufacturing capabilities and integrated development and analytical services to help you get more products and better treatments to clinic faster.

With our broad range of expert solutions we drive faster, more efficient development timelines to help you take more molecules to market and create more effective products. With more than 80 years of experience, we have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance and provide superior, reliable manufacturing. For more information, visit www.catalent.com/biologics

More products. Better treatments. Reliably supplied.™

Related resources

show more

Featured eBook: Complex Protein Production

Featured eBook: Complex Protein Production

Catalent Pharma Solutions | 06-Mar-2018 | Technical / White Paper

Download the eBook written by Catalent experts to learn about innovative products and techniques for scale-up of complex biologics, get optimal cell culture...

Novel Analytical Techniques For Monoclonal Antibodies

Novel Analytical Techniques For Monoclonal Antibodies

Catalent Pharma Solutions | 27-Mar-2017 | Insight Guide

With the rising interest in biopharmaceuticals, drug developers need to quickly understand and evaluate the binding of therapeutic antibodies to Fc receptors. ...

Proven compatibility of Biologics in ADVASEPT® Vials

Proven compatibility of Biologics in ADVASEPT® Vials

Catalent Pharma Solutions | 30-Nov-2015 | Clinical Study

The advanced aseptic processing of ADVASEPT® technology can reduce the risk associated with aseptic filling of biologics and drastically reduce the potential...

Bringing a Small Molecule to Clinic Ebook

Bringing a Small Molecule to Clinic Ebook

Catalent Pharma Solutions | 22-Sep-2015 | Technical / White Paper

It’s time to transition your molecule discovery to a commercial drug launch. While achieving rapid time to-market is critical, so is avoiding costly mistakes...